Targeting the glutamatergic system to develop novel therapeutics for mood and anxiety disorders

被引：0
|
作者：
Saitoh, Akiyoshi [1 ]
Yamada, Mitsuhiko [1 ]
机构：
[1] NCNP, NIMH, Dept Neuropsychopharmacol, Kodaira, Tokyo, Japan
来源：
JOURNAL OF PHARMACOLOGICAL SCIENCES | 2016年 / 130卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
2-S-11-3
引用
收藏
页码：S52 / S52
页数：1
相关论文
共 50 条
  • [21] Comment on “Novel Glutamatergic Modulators for the Treatment of Mood Disorders: Current Status“
    Marco Pappagallo
    Charles E. Inturrisi
    Paolo L. Manfredi
    CNS Drugs, 2022, 36 : 203 - 204
  • [22] Glutamatergic dysregulation in mood disorders: opportunities for the discovery of novel drug targets
    Malgorzata, Panek
    Pawel, Kawalec
    Iwona, Malinowska Lipien
    Brzostek, Tomasz
    Andrzej, Pilc
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2020, 24 (12) : 1187 - 1209
  • [23] Role of Orexin System in Anxiety and Mood Disorders
    Shekhar, Anantha
    Johnson, Philip L.
    Molosh, Andre
    BIOLOGICAL PSYCHIATRY, 2016, 79 (09) : 171S - 171S
  • [24] The Endocannabinoid System and the Treatment of Mood and Anxiety Disorders
    Hill, Matthew N.
    Gorzalka, Boris B.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2009, 8 (06) : 451 - 458
  • [25] Comment on "Novel Glutamatergic Modulators for the Treatment of Mood Disorders: Current Status"
    Pappagallo, Marco
    Inturrisi, Charles E.
    Manfredi, Paolo L.
    CNS DRUGS, 2022, 36 (02) : 203 - 204
  • [26] The role of the tripartite glutamatergic synapse in the pathophysiology and therapeutics of mood disorders (vol 15, pg 525, 2009)
    Machado-Vieira, R.
    Manji, H. K.
    Zarate, C. A.
    NEUROSCIENTIST, 2010, 16 (02): : 199 - 199
  • [27] Glutamatergic Modulators: The Future of Treating Mood Disorders?
    Zarate, Carlos, Jr.
    Machado-Vieira, Rodrigo
    Henter, Ioline
    Ibrahim, Lobna
    Diazgranados, Nancy
    Salvadore, Giacomo
    HARVARD REVIEW OF PSYCHIATRY, 2010, 18 (05) : 293 - 303
  • [28] Glutamatergic Synaptic Plasticity: A Window into Mood Disorders
    Du, Jing
    BIOLOGICAL PSYCHIATRY, 2011, 69 (09) : 116S - 116S
  • [29] Beyond monoamines: Glutamatergic function in mood disorders
    Kugaya, A
    Sanacora, G
    CNS SPECTRUMS, 2005, 10 (10) : 808 - +
  • [30] Recent advances in the neurobiology of anxiety disorders: Implications for novel therapeutics
    Mathew, Sanjay J.
    Price, Rebecca B.
    Charney, Dennis S.
    AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS, 2008, 148C (02) : 89 - 98
12345